Qiwei Chen

Shantou University, Shenzhen University

Papers

2

Total Citations

133

H-Index

2

About

Qiwei Chen is a pioneering researcher at the forefront of micro- and nanorobotics for biomedical applications, with a core focus on developing intelligent, biohybrid systems for targeted drug delivery and cancer therapy. Chen’s major contributions include the design of autonomous metal-organic framework (MOF) nanorobots capable of active, mitochondria-targeted cancer therapy—a breakthrough that addresses the formidable challenge of intracellular propulsion and subcellular organelle access. This work, published in 2023, has already garnered 95 citations, underscoring its impact. In another highly cited study (38 citations), Chen introduced multifunctional MOF exoskeletons that protect biohybrid sperm microrobots from environmental threats like antisperm antibodies, enabling robust active drug delivery. These innovations demonstrate a unique ability to merge materials science with cellular biology, creating “living” robots that overcome biological barriers. Chen’s work is notable for its translational potential, offering new paradigms for treating diseases at the cellular level. For students and researchers, Chen exemplifies how creative integration of nanochemistry and robotics can solve real-world medical challenges, inspiring the next generation of bioengineers.

Research Focus

Key Achievements

2
H-Index
2
Papers
133
Total Citations
67
Avg Citations/Paper
🏆 Most Cited Paper
Autonomous metal-organic framework nanorobots for active mitochondria-targeted cancer therapy
95 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Shantou University, Shenzhen University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago